Ownership history in CAXTON CORP · 15 quarters on record
This page tracks every 13F SEC filing in which CAXTON CORP reported a position in COMPASS THERAPEUTICS INC (CMPX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | REDUCED | 29,495 | -24,008 | -44.9% | 3.70% | $158K | $5.37 |
| 2025 Q3 | ADDED | 53,503 | +10,038 | +23.1% | 0.82% | $187K | $3.50 |
| 2025 Q2 | UNCHANGED | 43,465 | — | 0% | 1.15% | $113K | $2.60 |
| 2025 Q1 | UNCHANGED | 43,465 | — | 0% | 1.63% | $82.6M | $1.90 |
As of 2025 Q4 — sorted by position size